CIM news banner

Breadcrumb

Asset Publisher

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations

Canada Research Chairs Program announces new and renewed chairs

Congratulations to five RI-MUHC researchers!

Dr. Thomas Emmett Francoeur awarded the Prix Letondal

Pioneering work in child development recognized by the Association of Pediatricians of Quebec

At the heart of precision medicine

New translational collaboration aims to transform approach to heart muscle disease

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

COVID-19 Q&A: Tina Montreuil on helping children cope with anxiety

“It is not only what you say that matters, but what you do”

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine

New gift promotes respect for children’s voices

$1.1 million donation supports an interdisciplinary project spearheaded by researcher Franco Carnevale

Ovarian and endometrial cancers: $ 6M closer to a lifesaving screening pap test

Dr. Lucy Gilbert’s research team receives funding to finalize development of the DOvEEgene test

Dr. Franco Carli elected Chairman of the American Prehabilitation Society

Pioneering programs that make patients stronger prior to surgery

Bridging the gap between AI and the clinic

Open source app helps predict brain tumour malignancy and patient survival

The Pfizer Investigator Training Program comes to the RI-MUHC!

Clinical research educational training program benefits researchers, staff and students at the inaugural event

RI-MUHC researcher among the world’s most cited

Dr. Ron Postuma makes the 2019 Web of Science list!

Rare respiratory diseases: Combining immunology and respiratory expertise for children and adults

The RI-MUHC is one of eight research centres participating in an NIH-funded project to accelerate the understanding of rare suppurative respiratory diseases...

Opal app wins again!

Patient empowerment app developed by members of the Research Institute of the MUHC receives the Grand Prix de l’année

What is safe sedation in the ICU?

Dr. Yoanna Skrobik is co-author of an editorial in the New England Journal of Medicine

Gut bacteria associated with chronic widespread pain for first time

People with fibromyalgia show variations in microbiome composition

Patient empowerment app Opal wins Prix d'excellence honour

Technology and patient insight at the heart of innovative patient portal developed at the MUHC

See Archive - CIM News